FDA report finds J&J COVID-19 booster beneficial, despite limited data

A second dose of Johnson & Johnson’s coronavirus vaccine is likely beneficial to recipients, the Food and Drug Administration (FDA) said Wednesday, thoughthe data is extremely limited.In a briefing document released ahead of an advisory…